Latest Videos
Dr. Murad Mamedov, 2019 Michelson Prizes Human Immunome Project Recipient
Dr. Murad Mamedov, Postdoctoral Scholar, Microbiology and Immunology, School of Medicine, University of California, San Francisco, describes his research project titled “Mapping γδ T Cell Receptor Ligands.”
Dr. Kamal Mandal, 2019 Michelson Prizes Human Immunome Project Recipient
Dr. Kamal Mandal, University of California, San Francisco, describes his research project titled “‘Structural surfaceomics: an approach to identify cancer-specific cell surface protein conformations for immunotherapeutic targeting.”
Dr. Ansuman Satpathy, 2018 Michelson Prizes Human Immunome Project Recipient
Dr. Ansuman Satpathy, Assistant Professor, Department of Pathology, Stanford University School of Medicine, was awarded a 2018 Michelson Prize for Human Immunology and Vaccine Research for his work focused on combining disciplines of genomics and human immunology.
Dr. Laura Mackay, 2018 Michelson Prizes Human Immunome Project Recipient
Dr. Laura MacKay, Laboratory Head and Senior Lecturer, Peter Doherty Institute for Infection and Immunity, University of Melbourne, is studying a recently described subset of immune cells called tissue-resident memory T cells, which combat various viral infections and cancer.
Dr. Patricia Therese Illing, 2018 Michelson Prizes Human Immunome Project Recipient
Dr. Patricia Therese Illing of Monash University was awarded a 2018 Michelson Prize for Human Immunology and Vaccine Research for her work involving an innovative new approach for identifying influenza-specific peptide antigens.
Dr. Laura Kate Mackay: Are TRM Cells the Future of Vaccine and Cancer Treatments?
Dr. Laura Kate Mackay discusses her research on TRM cells and how they could be targeted to improve immune protection against disease and revolutionize the development of new vaccines and cancer therapies.
Dr. Ansuman Satpathy on Single-Cell Epigenome Technologies for Precision Immune Profiling
Dr. Satpathy discusses his work on single-cell epigenome technologies for precision immune profiling. He explains how these technologies can be used to study the immune system at a single-cell level, and improve our understanding of diseases to develop new treatments.
Dr. Patricia Therese Illing: How Spliced Peptides Could Revolutionize Influenza Vaccines
Dr. Patricia Therese Illing discusses her research on spliced peptides for influenza immunity. She explains how spliced peptides can be used to target the immune system to specific parts of the influenza virus.
The Future of Vaccines: What We Learned at the First Annual Conference
The Future of Vaccine Development Conference brought together leading scientists and researchers from around the world to discuss the latest advances in vaccines and to explore new ways to accelerate the development of vaccines against some of the world's most threatening diseases.
